Eli Lilly notched up its sixth acquisition this year with the buyout of Ajax Therapeutics for $2.3 billion. ・Other ...

Eli Lilly is spending up to $7.8 billion to buy Centessa, which is working on treatments for sleep-wake disorders. Eli Lilly has made yet another deal, this time buying a drug company that's ...

The weekly injection is now the first drug treatment option cleared for patients with obesity and moderate-to-severe obstructive sleep apnea, or OSA, which refers to breathing interrupted during sleep ...

INDIANAPOLIS — Eli Lilly is acquiring United Kingdom-based company Centessa Pharmaceuticals for up to $7.8 billion. Lilly’s purchase will allow them to expand into the sleep disorder treatment market.

March 31 (Reuters) - Eli Lilly said on Tuesday it would buy Centessa Pharmaceuticals in a deal valued at up to $7.8 billion as the U.S. ‌drugmaker looks to diversify beyond its metabolic portfolio and ...

Eli Lilly has agreed to acquire Centessa Pharmaceuticals in a deal valued at up to $7.8 billion, marking a significant expansion of the drugmaker’s neuroscience portfolio into sleep medicine. Under ...

Shaquille O’Neal has obstructive sleep apnea (OSA). We know that because he’s teamed with Eli Lilly on an unbranded awareness campaign called “Don’t Sleep on OSA.” We also know that Lilly, since last ...

Recon: Lilly’s Zepbound reduces obstructive sleep apnea in phase 3 trials; Sage abandons Parkinson's candidate after mid-stage study flop Welcome to Regulatory Reconnaissance, your regulatory news and ...

Many people think of sleep as a time when the body rests and recovers. But for millions of people around the world, sleep is ...

Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading.

It's acquiring an asset with a very promising lead drug candidate.